rs5877

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BA1BP4BS2_Supporting

This summary comes from the ClinGen Evidence Repository: The c.981A>G (p.Val327=) variant is reported at an Popmax FAF MAF of 0.7471 (19267/24962 alleles) in the African/African-American population in the genomes in gnomAD v2.1.1 with a total of 26873 homozygotes, meeting BA1 criteria of FAF >= 0.002. The variant has been reported in one heterozygous individual with normal AT activity levels (85%) meeting BS2_Supporting criteria. This synonymous variant is not predicted to impact splicing by SpliceAI and VARSEAK meeting BP4 criteria. In summary, this variant meets criteria to be classified as benign. ACMG/AMP criteria applied, as specified by the Thrombosis Variant Curation Expert Panel for SERPINC1: BA1, BP4, BS2_Supporting. LINK:https://erepo.genome.network/evrepo/ui/classification/CA1251300/MONDO:0013144/084

Frequency

Genomes: 𝑓 0.48 ( 20230 hom., cov: 33)
Exomes 𝑓: 0.36 ( 100463 hom. )

Consequence

SERPINC1
NM_000488.4 synonymous

Scores

2

Clinical Significance

Benign reviewed by expert panel B:8

Conservation

PhyloP100: 2.06

Publications

43 publications found
Variant links:
Genes affected
SERPINC1 (HGNC:775): (serpin family C member 1) The protein encoded by this gene, antithrombin III, is a plasma protease inhibitor and a member of the serpin superfamily. This protein inhibits thrombin as well as other activated serine proteases of the coagulation system, and it regulates the blood coagulation cascade. The protein includes two functional domains: the heparin binding-domain at the N-terminus of the mature protein, and the reactive site domain at the C-terminus. The inhibitory activity is enhanced by the presence of heparin. Numerous mutations have been identified for this gene, many of which are known to cause antithrombin-III deficiency which constitutes a strong risk factor for thrombosis. A reduction in the serum level of this protein is associated with severe cases of Coronavirus Disease 19 (COVID-19). [provided by RefSeq, Sep 2020]
SERPINC1 Gene-Disease associations (from GenCC):
  • hereditary antithrombin deficiency
    Inheritance: AD, AR, SD Classification: DEFINITIVE, STRONG, SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), PanelApp Australia, Genomics England PanelApp, Orphanet, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP4
For more information check the summary or visit ClinGen Evidence Repository.
BS2
For more information check the summary or visit ClinGen Evidence Repository.
BA1
For more information check the summary or visit ClinGen Evidence Repository.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000488.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SERPINC1
NM_000488.4
MANE Select
c.981A>Gp.Val327Val
synonymous
Exon 5 of 7NP_000479.1P01008
SERPINC1
NM_001386302.1
c.1104A>Gp.Val368Val
synonymous
Exon 5 of 7NP_001373231.1
SERPINC1
NM_001386303.1
c.1062A>Gp.Val354Val
synonymous
Exon 6 of 8NP_001373232.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SERPINC1
ENST00000367698.4
TSL:1 MANE Select
c.981A>Gp.Val327Val
synonymous
Exon 5 of 7ENSP00000356671.3P01008
SERPINC1
ENST00000874328.1
c.1110A>Gp.Val370Val
synonymous
Exon 5 of 7ENSP00000544387.1
SERPINC1
ENST00000874324.1
c.1104A>Gp.Val368Val
synonymous
Exon 5 of 7ENSP00000544383.1

Frequencies

GnomAD3 genomes
AF:
0.476
AC:
72443
AN:
152088
Hom.:
20178
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.766
Gnomad AMI
AF:
0.315
Gnomad AMR
AF:
0.414
Gnomad ASJ
AF:
0.539
Gnomad EAS
AF:
0.643
Gnomad SAS
AF:
0.385
Gnomad FIN
AF:
0.279
Gnomad MID
AF:
0.532
Gnomad NFE
AF:
0.338
Gnomad OTH
AF:
0.467
GnomAD2 exomes
AF:
0.402
AC:
100924
AN:
251348
AF XY:
0.396
show subpopulations
Gnomad AFR exome
AF:
0.777
Gnomad AMR exome
AF:
0.336
Gnomad ASJ exome
AF:
0.534
Gnomad EAS exome
AF:
0.671
Gnomad FIN exome
AF:
0.283
Gnomad NFE exome
AF:
0.341
Gnomad OTH exome
AF:
0.400
GnomAD4 exome
AF:
0.359
AC:
525175
AN:
1461580
Hom.:
100463
Cov.:
47
AF XY:
0.359
AC XY:
261338
AN XY:
727080
show subpopulations
African (AFR)
AF:
0.785
AC:
26275
AN:
33480
American (AMR)
AF:
0.343
AC:
15318
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.536
AC:
14002
AN:
26132
East Asian (EAS)
AF:
0.618
AC:
24552
AN:
39700
South Asian (SAS)
AF:
0.383
AC:
33036
AN:
86248
European-Finnish (FIN)
AF:
0.287
AC:
15323
AN:
53414
Middle Eastern (MID)
AF:
0.490
AC:
2827
AN:
5766
European-Non Finnish (NFE)
AF:
0.332
AC:
369383
AN:
1111734
Other (OTH)
AF:
0.405
AC:
24459
AN:
60382
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.461
Heterozygous variant carriers
0
18623
37246
55868
74491
93114
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
12224
24448
36672
48896
61120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.477
AC:
72557
AN:
152206
Hom.:
20230
Cov.:
33
AF XY:
0.472
AC XY:
35129
AN XY:
74426
show subpopulations
African (AFR)
AF:
0.766
AC:
31822
AN:
41540
American (AMR)
AF:
0.414
AC:
6332
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.539
AC:
1871
AN:
3470
East Asian (EAS)
AF:
0.642
AC:
3328
AN:
5180
South Asian (SAS)
AF:
0.385
AC:
1858
AN:
4824
European-Finnish (FIN)
AF:
0.279
AC:
2959
AN:
10598
Middle Eastern (MID)
AF:
0.558
AC:
164
AN:
294
European-Non Finnish (NFE)
AF:
0.338
AC:
22948
AN:
67986
Other (OTH)
AF:
0.467
AC:
989
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1726
3452
5179
6905
8631
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
614
1228
1842
2456
3070
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.398
Hom.:
23493
Bravo
AF:
0.501
Asia WGS
AF:
0.523
AC:
1819
AN:
3478
EpiCase
AF:
0.363
EpiControl
AF:
0.363

ClinVar

ClinVar submissions
Significance:Benign
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
4
Hereditary antithrombin deficiency (4)
-
-
2
not provided (2)
-
-
2
not specified (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.56
CADD
Benign
8.2
DANN
Benign
0.48
PhyloP100
2.1
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
2.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs5877; hg19: chr1-173878862; COSMIC: COSV62929421; COSMIC: COSV62929421; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.